R&D Tax Credit for Biotechnology

Biotechnology companies are strong candidates for government sponsored incentive programs such as the R&D Tax Credit. Capturing all potentially qualifying activities requires the exploration of multiple cost centers, not just the traditional R&D cost center. In many companies, successful formula development, process development, pilot batch production, scale-up processes, method development, and analytical testing of experimental or improved products involves extensive experimentation and testing to ensure product quality and process efficiency. In addition, many of the individuals involved in these research and development activities may not belong to the biological or chemical laboratory groups, and are often overlooked for purposes of the R&D tax credit. Examples of Biotechnology activities that present R&D tax credit opportunities include:

  • Development of new therapeutic drugs, compounds, or molecules used in synthesis experiments
  • Discovery and development of new methods for drug delivery
  • Development of biosimilars relating to advanced biologics, assays and testing protocols
  • Conducting clinical tests to satisfy government regulatory requirements prior to commercialization
  • Generation of pilot batches of new products for testing and validation
  • Design and development of new or improved scaled-up manufacturing processes

Businesses in the Biotechnology industry are likely candidates to receive cash benefits from an R&D tax credit study. Intrepid Advisors' experts can deliver maximum benefits for each tax year.

Company Profile

Annual Revenue:
$10-$25 Million

Employees:
25 - 50

R&D Tax Credits

Federal R&D Tax Credit:
$402,077

State R&D Tax Credit:
$53,883

R&D Tax Credit for Biotechnology

Learn More About R&D Tax Credits